Genmab A/S (NASDAQ:GMAB) Accelerates Growth With Merus Acquisition, Faces Near-Term Repricing
![]() |
Balance between asset-led expansion and heavier leverage shifts valuation dynamics; near-term price action will reflect execution on late‑stage programs and financing outcomes. |










